Cholecystectomy

Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter and Full Year 2022

Retrieved on: 
Thursday, March 2, 2023
Cloud, NYSE, 3D, Image, Robotics, Cholecystectomy, Investment, Growth, Regulation, Safety, GAAP, CE marking, File, Karl Storz SE, Gynaecology, Freedom, Anatomy, Bank statement, Collection, MDR, KARL, Annual report, PARK, Surgeon, U.S. FDA, Urology, European, Digital, Hospital, Cloud computing, Software, FDA, General surgery, Machine learning, LUNA, Health, Active Intelligence Pte Ltd, Security (finance), Google Cloud, CIS, ISU, PGS, RESEARCH, Pharmaceutical industry, Cryptocurrency, Dentistry, Rare-earth element, Video game, Medical device

“As we look to the future, we are incredibly excited about the opportunity we have to revolutionize patient care through Performance-Guided Surgery.

Key Points: 
  • “As we look to the future, we are incredibly excited about the opportunity we have to revolutionize patient care through Performance-Guided Surgery.
  • These instruments were commercially launched in the U.S., Japan and Europe, in the fourth quarter of 2022.
  • The Company submitted its U.S. FDA 510(k) application for pediatric clearance in the U.S. during the third quarter of 2022.
  • The Company had cash, cash equivalents, short-term and long-term investments, excluding restricted cash of approximately $74.4 million as of December 31, 2022.

Surgical Robots Market worth $18.4 billion by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, January 31, 2023
Neurosurgery, Cholecystectomy, Hospital, Obesity, Surgeon, Growth, Bariatric surgery, Prevalence, General surgery, Heller myotomy, Product-service system, Pancreatectomy, Hospital Clinic Manuel Quintela, Laparoscopy, Gastrectomy, Medical device, Dentistry

In 2021, the robotic systems segment accounted for the second largest share of the surgical robots market.

Key Points: 
  • In 2021, the robotic systems segment accounted for the second largest share of the surgical robots market.
  • The growing focus on adopting technologically advanced surgical robots and instruments among end users has fueled the market growth in this segment.
  • By robotic systems, the surgical robots market has been segmented into laparoscopy robotic systems, orthopedic robotic systems, neurosurgical robotic systems, and other systems.
  • By application, the surgical robots market has been segmented into general surgery, urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and other applications.

Surgical Robots Market worth $18.4 billion by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, January 31, 2023
Neurosurgery, Cholecystectomy, Hospital, Obesity, Surgeon, Growth, Bariatric surgery, Prevalence, General surgery, Heller myotomy, Product-service system, Pancreatectomy, Hospital Clinic Manuel Quintela, Laparoscopy, Gastrectomy, Medical device, Dentistry

In 2021, the robotic systems segment accounted for the second largest share of the surgical robots market.

Key Points: 
  • In 2021, the robotic systems segment accounted for the second largest share of the surgical robots market.
  • The growing focus on adopting technologically advanced surgical robots and instruments among end users has fueled the market growth in this segment.
  • By robotic systems, the surgical robots market has been segmented into laparoscopy robotic systems, orthopedic robotic systems, neurosurgical robotic systems, and other systems.
  • By application, the surgical robots market has been segmented into general surgery, urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and other applications.

Surgical Robots Market worth $14.4 billion by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, December 14, 2022
Heller myotomy, Neurosurgery, Growth, Gastrectomy, Cholecystectomy, Bariatric surgery, General surgery, Pancreatectomy, Dentistry

Based on product & service, the surgical robots market is segmented into robotic systems, instruments & accessories, and services.

Key Points: 
  • Based on product & service, the surgical robots market is segmented into robotic systems, instruments & accessories, and services.
  • The instruments & accessories segment accounted for the largest share of 53.8% of the market.
  • The surgical robots market, based on application is segmented into general surgery, urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and other applications.
  • Growth in this market segment can be attributed to the increased use of surgical robots in general procedures such as bariatric surgery, Heller myotomy, gastrectomy, hernia repair, cholecystectomy, transoral surgery, and pancreatectomy.

Surgical Robots Market worth $14.4 billion by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, December 14, 2022
Heller myotomy, Neurosurgery, Growth, Gastrectomy, Cholecystectomy, Bariatric surgery, General surgery, Pancreatectomy, Dentistry

Based on product & service, the surgical robots market is segmented into robotic systems, instruments & accessories, and services.

Key Points: 
  • Based on product & service, the surgical robots market is segmented into robotic systems, instruments & accessories, and services.
  • The instruments & accessories segment accounted for the largest share of 53.8% of the market.
  • The surgical robots market, based on application is segmented into general surgery, urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and other applications.
  • Growth in this market segment can be attributed to the increased use of surgical robots in general procedures such as bariatric surgery, Heller myotomy, gastrectomy, hernia repair, cholecystectomy, transoral surgery, and pancreatectomy.

Medical Simulation Global Market to Reach $4.1 Billion by 2027 at a CAGR of 13.68%

Retrieved on: 
Thursday, December 1, 2022
COVID-19, Environment, Hospital, Artificial intelligence, Patient safety, Appendectomy, Physician, Virtual reality, Ramakanta Panda, Nursing, Hysterectomy, Cholecystectomy, Robotics, Surgeon, Feedback, Augmented reality, AR, Co-production (public services), Medical device, Growth

The global medical simulation market size reached US$ 1.9 Billion in 2021.

Key Points: 
  • The global medical simulation market size reached US$ 1.9 Billion in 2021.
  • Looking forward, the publisher expects the market to reach US$ 4.1 Billion by 2027, exhibiting a CAGR of 13.68% during 2021-2027.
  • Medical simulation uses body manikins, task trainers and virtual reality (VR)-based systems for laparoscopic, gynecological, cardiovascular, arthroscopic, spinal, endovascular, dental and eye simulation.
  • The publisher provides an analysis of the key trends in each sub-segment of the global medical simulation market report, along with forecasts at the global, regional and country level from 2022-2027.

Medical Simulation Global Market Report 2022: Increasing Awareness of the Benefits of Simulation-Based Medical Learning Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, November 25, 2022
General Health, Radiology, Oncology, Training, Other Education, Hospitals, Health Technology, Education, Surgery, Nursing, Practice Management, Health, COVID-19, Environment, Hospital, Artificial intelligence, Patient safety, Appendectomy, Physician, Virtual reality, Ramakanta Panda, Nursing, Hysterectomy, Cholecystectomy, Robotics, Surgeon, Feedback, Augmented reality, AR, Co-production (public services), Medical device, Growth

The "Medical Simulation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Medical Simulation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • The global medical simulation market size reached US$ 1.9 Billion in 2021.
  • Moreover, the increasing awareness regarding the benefits of simulation-based learning among the masses is providing a thrust to the market growth.
  • The publisher provides an analysis of the key trends in each sub-segment of the global medical simulation market report, along with forecasts at the global, regional and country level from 2022-2027.

Olympus Launches VISERA ELITE III Surgical Visualization Platform

Retrieved on: 
Wednesday, September 14, 2022
Medical Supplies, Health, Medical Devices, Hospitals, Surgery, Health Technology, General Health, Laparoscopy, Observation, Software, Olympus, 3D, Efficiency, Gynaecology, Movement, Olympus Corporation, Twitter, Endoscopy, Sale, EDOF, Sony, Blood, Representative, Corporation, Google Images, Patient, Cholecystectomy, Technology, Quality of life, Standard of care, General surgery, EMEA, ENT, Surgeon, Surgical Endoscopy, HCPS, NBI, Hospital, Multimedia, Urology, Medical device

View the full release here: https://www.businesswire.com/news/home/20220913005632/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220913005632/en/
    Surgical visualization platform VISERA ELITE III (Photo: Business Wire)
    With VISERA ELITE III, we provide a best-in-class surgical visualization platform designed for multiple medical specialties and configurations, allowing HCPs to fully focus on the patient during surgery.
  • By incorporating the technologies of its predecessors VISERA ELITE II and VISERA 4K UHD into one platform, VISERA ELITE III enhances the quality of endoscopic surgery, contributes to improved efficiency in the operating room, and hereby elevates the standard of care, said Kanichi Matsumoto, Global Head of Surgical Endoscopy at Olympus.
  • VISERA ELITE III system integrates the 3D and infrared1 imaging functions from VISERA ELITE II, and the 4K imaging function from VISERA 4K UHD system.
  • In developing VISERA ELITE III, Sony Olympus Medical Solutions, a joint venture company of Sony and Olympus, optimized each technology and image processing function specifically for medical applications to create the most advanced, open, and versatile surgical visualization platform Olympus has ever brought to market.

EndoQuest Robotics Endoluminal Surgical (ELS) System Wins 2022 Surgical Robotic Challenge (Best Application Award)

Retrieved on: 
Thursday, August 18, 2022
FDA, Regulation of tobacco by the U.S. Food and Drug Administration, Surgeon, Zenker, Endoscopy, Robotics, Technology, Sale, Percussion section, Social robot, Achievement, Cholecystectomy, Patient, Review, Company, Scar, Appendectomy, IDE, Colon, ELS, 14th Weather Squadron, Anatomy, Sofie (surgical robot), Food, Adoption, Medical device, Medical imaging

HOUSTON, Aug. 18, 2022 /PRNewswire/ -- ENDOQUEST Robotics, developer of the world's first flexible endoluminal robotic system which enables scar-free and less invasive surgical procedures announced that the Company's Endoluminal Surgical (ELS) System was named the winner of the Best Application Award in the 2022 Surgical Robotic Challenge.

Key Points: 
  • HOUSTON, Aug. 18, 2022 /PRNewswire/ -- ENDOQUEST Robotics, developer of the world's first flexible endoluminal robotic system which enables scar-free and less invasive surgical procedures announced that the Company's Endoluminal Surgical (ELS) System was named the winner of the Best Application Award in the 2022 Surgical Robotic Challenge.
  • The award was presented on June 28, 2022 during the 14th Hamlyn Symposium on Medical Robotics held in London.
  • The Surgical Robotic Challenge is an international competition that attracts some of the leading surgical robotics groups from around the world to showcase innovative new ideas across a range of surgical robot platforms.
  • EndoQuest Robotics has developed the Endoluminal Surgical (ELS) System, the world's first endoluminal robotic surgical system that makes it possible for therapeutic endoscopists and surgeons to perform upper and lower gastrointestinal surgery less-invasively through a trans-oral or trans-anal approach.

iFHP and HCCI Release 2022 International Health Cost Comparison Report

Retrieved on: 
Wednesday, July 20, 2022
HCCI, Industry, CEO, Research, Partnership, List of international sports federations, Data, Plasma protein binding, Cholecystectomy, Patent, COVID-19, New Jersey Plan, Policy, Elijah Cummings Lower Drug Costs Now Act, Overalls, Journalism, Decision-making, Hip, Cataract, Hospital, Health insurance, Pharmaceutical industry, Sertraline

LONDON, July 20, 2022 /PRNewswire/ -- The International Federation of Health Plans (iFHP), an executive network of the global health insurance industry based in London, in partnership with the Health Care Cost Institute (HCCI) in the United States, and iFHP member companies in multiple countries, today published the latest International Health Cost Comparison Report.

Key Points: 
  • LONDON, July 20, 2022 /PRNewswire/ -- The International Federation of Health Plans ( iFHP ), an executive network of the global health insurance industry based in London, in partnership with the Health Care Cost Institute ( HCCI ) in the United States, and iFHP member companies in multiple countries, today published the latest International Health Cost Comparison Report.
  • The expanded report compares the cost of a selection of inpatient treatments, outpatient treatments and prescribed drugs as reported by iFHP members in eleven countries in 2019.
  • The Health Care Cost Institute (HCCI) is an independent, non-profit organization with leading health claims datasets that enable research, policy, and journalism.
  • The 2022 International Health Cost Comparison Report compares the cost of a selection of inpatient treatments, outpatient treatments and prescribed drugs as reported by iFHP members in ten countries in 2019.